BML 4694.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4694.T. It has been listed since 25 April 2001. In the fiscal year to 31 March 2026, it reported revenue of ¥150.26bn and net income of ¥7.75bn. At that date it held total assets of ¥183.25bn and shareholders' equity of ¥127.67bn.

BML, Inc. engages in the clinical and medical laboratory testing services for hospitals and clinics. The company is headquartered in Shibuya-Ku, Tokyo-To. The company went IPO on 2001-04-25. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Kensuke KondoPresident, Executive Officer, Chairman of Subsidiaries, Representative Director, since 2004¥121.0m
• Mr. Nobuki AraiVice President, Executive Officer, Director of BML Research Institute, Manager of Overseas Business Office, Representative Director, since 2009
• Mr. Norihisa TakebeSenior Managing Executive Officer, Chief Director of Planning, Director, since 2016
• Mr. Hiroyuki KigoshiManaging Executive Officer
• Mr. Masami KondoManaging Executive Officer, Chief Director of Director of Hospital Inspection, Director of Second In-Hospital Inspection
• Mr. Hideaki OsawaExecutive Officer, Chief Director of Sales, Director of Proposal Sales, Director of Pharmaceutical Clinical Trial Sales, Director, since 2016
• Mr. Toshihiro YanomaExecutive Officer, Director of Medical Information System Sales
• Mr. Kenji ShibataExecutive Officer, Chief Director of BML Inspection, Director of Inspection Planning, Director of 2nd Research Institute Inspection, Director of 4th Research Institute Inspection, Director, since 2018
• Mr. Yuji YamashitaExecutive Officer, Chief Director of System, Director, since 2018
• Mr. Michihiro AonoExecutive Officer, Director of Reliability Assurance
• Mr. Satoshi EnomotoExecutive Officer, since 2014
• Mr. Hiromi NakaharaExecutive Officer, Director of Risk Administration

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.